SCHEMBL30071250

SCHEMBL30071250

CCC(=O)Nc1ccccn1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.76
▸ NPC1 O15118 5/20 0.63
▸ RAB9A P51151 5/20 0.63
▸ PKM P14618 2/20 0.63
▸ SMN1; SMN2 Q16637 3/20 0.62
▸ HSD17B10 Q99714 2/20 0.62
▸ TP53 P04637 2/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ HDAC3 O15379 2/20 0.59
▸ HDAC4 P56524 2/20 0.59
▸ HDAC1 Q13547 2/20 0.59
▸ HDAC7 Q8WUI4 2/20 0.59
▸ HDAC2 Q92769 2/20 0.59
▸ HDAC10 Q969S8 2/20 0.59
▸ HDAC11 Q96DB2 2/20 0.59
▸ HDAC8 Q9BY41 2/20 0.59
▸ HDAC6 Q9UBN7 2/20 0.59
▸ HDAC9 Q9UKV0 2/20 0.59
▸ HDAC5 Q9UQL6 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626827 1.00 GAA (0.76) GAANPC1RAB9APKMSMN1; SMN2
Bromide SCHEMBL11500766 0.98 GAA (0.73) GAANPC1RAB9APKMSMN1; SMN2
Trifluoromethylbenzene SCHEMBL10520526 0.87 GAA (0.58) GAANPC1RAB9APKMSMN1; SMN2
SCHEMBL6245092 0.86 GAA (1.00) GAANPC1RAB9APKMSMN1; SMN2
SCHEMBL2562391 0.86 GAA (0.71) GAANPC1RAB9APKMSMN1; SMN2
SCHEMBL9689348 0.84 GAA (0.79) GAANPC1RAB9APKMSMN1; SMN2
SCHEMBL4491035 0.83 GAA (0.79) GAANPC1RAB9APKMSMN1; SMN2
SCHEMBL7006640 0.83 GAA (0.79) GAANPC1RAB9APKMSMN1; SMN2
SCHEMBL23976543 0.83 GAA (0.67) GAANPC1RAB9APKMSMN1; SMN2
SCHEMBL10790442 0.83 HDAC3 (0.70) GAANPC1RAB9APKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110945007-B 15 beta- [ 3-propionylamino ] -substituted estra-1, 3,5 (10) -trien-17-one compounds and 17-oximes thereof for inhibiting 17 beta-hydroxysteroid dehydrogenases 佛恩多制药有限公司 2022-11-18 — — CN claimed
CN-115716860-A 15 beta- [ 3-propionylamino ] -substituted estra-1, 3,5 (10) -trien-17-ones and 17-oximes 佛恩多制药有限公司 2023-02-28 — — CN disclosed
CN-110945007-B 15 beta- [ 3-propionylamino ] -substituted estra-1, 3,5 (10) -trien-17-one compounds and 17-oximes thereof for inhibiting 17 beta-hydroxysteroid dehydrogenases 佛恩多制药有限公司 2022-11-18 — — CN disclosed
Send feedback